HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe

DME MACs to Hold Meeting on Proposed LCDs for Seat Elevation on Group 2 Power Chairs
Mobility Management and HME Business to host March 19 webinar ahead of DME MACs' open meeting.

February 20, 2026 by Laurie Watanabe

Almost three years after the Centers for Medicare & Medicaid Services (CMS) announced Medicare coverage for power seat elevation on power wheelchairs, the Medicare DME MACs — Noridian Healthcare Solutions (Jurisdictions A and D) and CGS Administrators (Jurisdictions B and C) — said they’ll hold a March 25 meeting to discuss proposed local coverage determinations (LCDs) that would deny Medicare coverage of power seat elevation for Group 2 power chairs.

Several industry policy and clinical experts contacted by HME Business’s sister publication Mobility Management were surprised by the DME MACs’ announcement, but emphasized the importance of a measured and thoughtful response from stakeholders.

Julie Piriano, senior director, payer relations and regulatory affairs for the National Coalition for Assistive and Rehab Technology (NCART), told Mobility Management that the organization was creating a stakeholder committee to respond to the DME MACs’ plans and to coordinate comments from the industry.

What the proposed LCDs say

According to the DME MACs, the first proposed LCD covers power mobility devices and recommends “a not reasonable and necessary determination for Group 2 power wheelchairs (PWCs) with seat elevation systems (K0830 and K0831), based on the best available evidence.”

The second proposed LCD, for wheelchair options and accessories, recommends “a not reasonable and necessary determination for the use of seat elevation added onto non-complex power wheelchairs, based on the best available evidence.” It also proposes to include, in the coverage criteria for power tilt and/or recline seating systems, examples of clinical conditions that limit the beneficiary’s ability to perform a functional weight shift.

The DME MACs noted that the May 2023 national coverage determination gave them the authority to determine coverage for power seat elevation on non-Complex Rehab power wheelchairs.

Public meeting in late March

Registration for the March 25 virtual meeting opened Feb. 19. A 45-day public comment period will remain open through April 4, Piriano told potential workgroup members in a Feb. 19 email.

Piriano also invited stakeholders who wish to participate in the response to reach out directly: [email protected].

Mobility Management and HME Business will host a March 19 webinar to provide NCART and other industry stakeholders a platform to discuss their comments. Registration is free and now open.

 

Related Articles Read More >

Cardinal at-Home Solutions Acquires AdaptHealth’s Diabetes Unit and DME Supplier Strive Medical
The two acquisitions cost approximately $360 million in cash.
AASM Denounces Passage of House Bill to Make Daylight Saving Time Permanent
The American Academy of Sleep Medicine advocates for permanent adoption of standard time.
Merits Health Products Appoints Bret Tracy as VP of Sales and Marketing
The industry veteran returned to the power mobility and CRT manufacturer this month.
HME Business Parent Company Rebrands as Arrowfly

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe